Canopy Biosciences exclusively licenses technology for error correction in NGS from Washington University

March 11, 2019 Leave a comment 2,493 Views

Canopy Biosciences™ LLC, a leading provider of gene editing and gene expression products and services, announced today that they had exclusively licensed technology for error correction in next generation...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: Canopy Biosciences

Canopy Biosciences exclusively licenses technology for error correction in NGS from Washington University

A new blood-based RNA sequencing method to detect coronary artery disease

Crafting a blueprint for single-cell RNA sequencing

UICPC – Centrality-based clustering for scRNA-seq data analysis without user input

Single nucleus RNA sequencing identifies inflamed brain cells likely involved in MS nerve degeneration

Exogene – A performant workflow for detecting viral integrations from paired-end next-generation sequencing data

RNALocate v2.0 – an updated resource for RNA subcellular localization with increased coverage and annotation

A precision oncology framework to predict patient response to cancer therapy from the tumor transcriptome